Generics 22

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Granisetron hydrochloride manufacturers

22 products found

Filters

22 products found

granisetron hydrochloride

Ampoules, injection 3 mg/3 ml - 3 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
South Africa
Manufacturer #638

Manufacturer usually replies in 8 days

granisetron hydrochloride

Tablets 1 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP
Manufacturer #18353

Manufacturer usually replies in 10 days

granisetron hydrochloride

Injection 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19740

Manufacturer usually replies in 1 days

granisetron hydrochloride + glucose

Injection 50ml:3mg:2.5g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
WHO
Manufacturer #17087

Manufacturer usually replies in 3 days

granisetron hydrochloride

Solution for injection 1mg/1ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
British Virgin Islands
GMP approvals
WHO
Available for
Licensing with supply, Distribution only
Manufacturer #17771

Manufacturer usually replies in 3 days

granisetron hydrochloride

Injection 2 mg, 1 mg, 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

granisetron hydrochloride

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

granisetron hydrochloride

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

granisetron hydrochloride

Injection 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19200

Manufacturer usually replies in 6 days

granisetron hydrochloride

Ampoules, injection 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18075
The mission of all pharmaceutical companies and employees is to fight disease and protect those who suffer or lose their lives. Therefore, the development, production, and supply of excellent pharmaceuticals are a fundamental responsibility of pharmaceutical companies. Based on the research, production, and sales capabilities from API to Drug products using purely their technology, they are leaping to become the global No. 1 bio & chemical-pharmaceutical company in various areas including next-generation biopharmaceuticals, from gene therapy to antibody therapy, cell therapy, and natural medicine.

Manufacturer usually replies in 9 days

granisetron hydrochloride

Tablets 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18075
The mission of all pharmaceutical companies and employees is to fight disease and protect those who suffer or lose their lives. Therefore, the development, production, and supply of excellent pharmaceuticals are a fundamental responsibility of pharmaceutical companies. Based on the research, production, and sales capabilities from API to Drug products using purely their technology, they are leaping to become the global No. 1 bio & chemical-pharmaceutical company in various areas including next-generation biopharmaceuticals, from gene therapy to antibody therapy, cell therapy, and natural medicine.

Manufacturer usually replies in 9 days

granisetron hydrochloride

Solution for injection 1mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #16167

Manufacturer usually replies in 7 days

granisetron hydrochloride

Solution for injection 1mg/1ml, 3mg/3ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
Manufacturer #13135
The company has become a respected global health care group. The company has great growth potential. They use DDS source technology and an excellent pipeline to secure long-term growth. They are focused on profitability in a highly competitive market with new drugs and niche buster product launch technology.

Manufacturer usually replies in 7 days

granisetron hydrochloride

Tablets 1mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
Manufacturer #13135
The company has become a respected global health care group. The company has great growth potential. They use DDS source technology and an excellent pipeline to secure long-term growth. They are focused on profitability in a highly competitive market with new drugs and niche buster product launch technology.

Manufacturer usually replies in 7 days

granisetron hydrochloride

Injection 1 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19639

Manufacturer usually replies in 12 days

granisetron hydrochloride

Injection 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19051

Manufacturer usually replies in 14 days

granisetron hydrochloride

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
FDA
Manufacturer #21935

Manufacturer usually replies in 35 days

granisetron hydrochloride

Ampoules, injection 3 mg, 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
FDA
Manufacturer #21935

Manufacturer usually replies in 35 days

granisetron hydrochloride

Injection 0.2 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #28571

Manufacturer usually replies in nan days

granisetron hydrochloride

Injection 3 mg - 100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31064

Want to view all 22 products? Create your free account today!

Granisetron Hydrochloride Manufacturers

Granisetron Hydrochloride works by inhibiting the actions of chemicals in the body that cause nausea and vomiting. Granisetron Hydrochloride was developed around 1985 by chemists at the British pharmaceutical company Beecham and is now available as a generic. Roche Laboratories manufactures it under the brand name Kytril. The FDA approved the drug in the United Kingdom in 1991 and in the United States in 1994. On September 12, 2008, the US Food and Drug Administration approved the Sancuso granisetron transdermal patch. 3M Drug Delivery Systems manufactures Sancuso for Kyowa Kirin, Inc. Granisetron Hydrochloride is a drug that is well-tolerated and has few side effects. The most commonly reported side effects of its use are headache, dizziness, and constipation. There have been no reports of significant drug interactions with this drug's use. It is degraded by the liver's cytochrome P450 system and has little effect on the metabolism of other drugs degraded by this system. Granisetron has been linked to a heart rhythm disorder (QT prolongation). QT prolongation can cause severe (rarely fatal) fast heart rate and other illnesses (such as severe dizzy spells and lightheadedness) that require immediate medical attention.

How does Granisetron Hydrochloride work?

Granisetron Hydrochloride is a medication that is used to treat illnesses caused by cancer chemotherapy and radiation therapy. Granisetron Hydrochloride belongs to a class of drugs known as 5-HT3 receptor antagonists. It works by preventing the release of serotonin, a naturally occurring substance in the body that causes nausea and vomiting.

Wholesale Price of Granisetron Hydrochloride

An online search for the wholesale price for sale of Granisetron Hydrochloride for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Granisetron Hydrochloride distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Granisetron Hydrochloride suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Granisetron Hydrochloride. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Granisetron Hydrochloride is already registered in. Manufacturers also have special, and delivery terms.

Establishing Commercial Ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers and Granisetron Hydrochloride suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Granisetron Hydrochloride Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.